Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

$PRCTPress releaseAug 26, 2026, 10:11 PM ETRead the release

Kahn Swick & Foti reminded investors of the September 22, 2026 lead plaintiff deadline in a securities class action against PROCEPT BioRobotics. The lawsuit alleges that the company failed to disclose material information regarding excess field inventory and a disconnect between handpiece sales and procedures.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.